Met Life Investment Management, LLC Wave Life Sciences Ltd. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 55,941 shares of WVE stock, worth $591,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,941
Previous 43,601
28.3%
Holding current value
$591,296
Previous $357,000
93.56%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding WVE
# of Institutions
192Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$192 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$102 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$87.3 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$71.2 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$71 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $918M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...